Remgro Lifts Dividend 80% as Portfolio Momentum Accelerates Into 2026 Johann Rupert’s Remgro Delivers a Bumper Half as Mediclinic and CIVH Drive Earnings Remgro’s Investee Dividend Surge Powers a Record Interim Payout
Remgro, the Stellenbosch-based investment holding company controlled by billionaire Johann Rupert, has raised its interim dividend by 80.2% to 173 cents per share after a strong first half driven by improved performances across its diversified portfolio of investee companies. The declaration covers the six months ended December 2025 and follows a full-year period in which the group paid a special dividend of 200 cents per share linked to the disposal of its British American Tobacco stake — a transaction that marked one of the most significant portfolio reshaping exercises in the group’s recent history.
Headline earnings for the period increased 38.8% to R5.175 billion, while headline earnings per share rose 38.5% to 931 cents. The earnings recovery reflects a broad-based improvement across the portfolio, with Mediclinic contributing R485 million, Rainbow Chicken R280 million, Community Investment Ventures Holdings R264 million, and Heineken Beverages R166 million. TotalEnergies Marketing South Africa contributed a further R330 million, though that figure included a one-off Transnet pipeline cost refund and is therefore not considered recurring. Finance costs declined following the redemption of preference shares in the prior year, partially offsetting a weaker contribution from RCL Foods, where the sugar business unit underperformed. Remgro’s intrinsic net asset value per share stood at R292.34 as at June 2025, with its share price at the time representing a discount of approximately 46% to intrinsic NAV — a persistent feature of South African holding company valuations that management has consistently identified as the central challenge in its value-unlock strategy.
READ – Remgro Issues Special Dividend Thanks To Portfolio Success
The most significant cash event of the half-year was the conclusion of the CIVH-Vodacom transaction in December 2025, through which Vodacom acquired a 40% stake in Maziv — a newly created subsidiary housing CIVH’s fibre infrastructure assets, including Vumatel and Dark Fibre Africa. The deal, which had been in regulatory limbo since the Competition Commission recommended its prohibition in 2023, was ultimately cleared by the Competition Tribunal. The transaction generated a pre-implementation dividend of R2.66 billion for Remgro, excluded from the group’s sustainable dividend figure of R2.428 billion — itself 34% higher than the prior comparable period. Sustainable dividends received from investee companies are the primary measure Remgro uses to assess the recurring cash generation capacity of the portfolio, and the 34% increase signals that the underlying businesses are generating materially more cash than a year ago. More than 80% of Remgro’s portfolio achieved headline earnings growth in the prior full year, a trend that has continued into the current period and is reflected in the scale of the dividend increase.
Remgro’s management has introduced a note of caution around the geopolitical environment, specifically the conflict between the United States, Israel, and Iran. The group has direct exposure to the Middle East through Mediclinic’s hospital and clinic operations in the United Arab Emirates, a business that has been one of the stronger performers in the Mediclinic portfolio and whose prospects are closely linked to regional stability and consumer spending confidence. Beyond the direct UAE exposure, the group has flagged broader risks to global asset prices stemming from the conflict — rising inflation, higher cost of capital, and the impact on emerging market valuations — as variables it is monitoring carefully given the emerging market skew of its portfolio.
As detailed on Remgro’s investor centre, the group said it had made measurable progress on portfolio optimisation through corporate actions during the period, and expressed confidence that its strategic discipline was driving the improved period-on-period performance and the strong central cash generation the results reflect. For the full year ended June 2025, Remgro declared a gross ordinary dividend of 344 cents per share, up from 264 cents in 2024, alongside the 200 cents special dividend linked to the BAT disposal. The 173 cents interim dividend declared this week places the group on a trajectory that, if sustained, would result in a record full-year ordinary dividend when results for the year ended June 2026 are published later this year.
BEFORE YOU GO – Remgro’s Earnings Skyrocket